Center for Technology Commercialization

Estrigenix Therapeutics was one of five Wisconsin-based companies awarded matching funding from the SBIR Advance Phase 1 program funded by the Wisconsin Economic Development Corporation. The SBIR Advance program provides assistance to companies in the process of completing a project in the federal Small Business Innovation Research (SBIR) program. feedback and reviewed multiple proposals from … Estrigenix Therapeutics one of five Wisconsin companies awarded SBIR Advance Phase 1 funding from WEDC

Estrigenix Therapeutics,  Inc.’s chief scientific officer, Karyn Frick PhD was recently featured in Center for Technology Commercialization talking about the process Estrigenix went through to receive Small Business Innovation Research (SBIR) Ready funding. The SBIR Ready program provided feedback and reviewed multiple proposals from Estrigenix before giving Estrigenix the green light for the SBIR Ready … Estrigenix Therapeutics, Inc.’s Chief Scientific Officer Karyn Frick PhD featured in Center for Technology Commercialization